Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage

Experimental Physiology

Volumn 93, Issue 11, 2008, Pages 1190-1198

  Gehrig, Stefan M ^a   Ryall, James G ^a   Schertzer, Jonathan D ^a   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DISEASE PREDISPOSITION; EXTENSOR DIGITORUM LONGUS MUSCLE; HISTOPATHOLOGY; MALE; MOUSE; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN BLOOD LEVEL;

EID: 53949118974     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2008.042838     Document Type: Article

References (31)

1. 3H]ryanodine binding to rabbit and frog skeletal muscle. Am J Physiol Cell Physiol 266, C462 C466.
2. Barton ER, Morris L, Musaro A, Rosenthal N & Sweeney HL (2002). Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157, 137 148.
3. Brooks SV (1998). Rapid recovery following contraction-induced injury to in situ skeletal muscles in mdx mice. J Muscle Res Cell Motil 19, 179 187.
4. Consolino CM & Brooks SV (2004). Susceptibility to sarcomere injury induced by single stretches of maximally activated muscles of mdx mice. J Appl Physiol 96, 633 638.
5. De Luca A, Pierno S, Camerino C, Cocchi D & Camerino DC (1999). Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromuscul Disord 9, 11 18.
6. Emery AE (2002). The muscular dystrophies. Lancet 359, 687 695.
7. Firth SM & Baxter RC (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23, 824 854.
8. Gregorevic P, Allen JM, Minami E, Blankinship MJ, Haraguchi M, Meuse L, Finn E, Adams ME, Froehner SC, Murry CE & Chamberlain JS (2006). rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12, 787 789.
9. Gregorevic P, Plant DR, Leeding KS, Bach LA & Lynch GS (2002). Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol 161, 2263 2272.
10. Gregorevic P, Plant DR & Lynch GS (2004). Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle Nerve 30, 295 304.
11. Harcourt LJ, Holmes AG, Gregorevic P, Schertzer JD, Stupka N, Plant DR & Lynch GS (2005). Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. Am J Pathol 166, 1131 1141.
12. Ingalls CP, Warren GL, Williams JH, Ward CW & Armstrong RB (1998). E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. J Appl Physiol 85, 58 67.
13. Jones JI & Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16, 3 34.
14. Koenig M, Monaco AP & Kunkel LM (1988). The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219 228.
15. Krag TO, Bogdanovich S, Jensen CJ, Fischer MD, Hansen-Schwartz J, Javazon EH, Flake AW, Edvinsson L & Khurana TS (2004). Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci USA 101, 13856 13860.
16. Lynch GS (2004). Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy. Clin Exp Pharmacol Physiol 31, 557 561.
17. Moens P, Baatsen PH & Marechal G (1993). Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14, 446 451.
18. Petrof BJ, Shrager JB, Stedman HH, Kelly AM & Sweeney HL (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90, 3710 3714.
19. Reimann J, Irintchev A & Wernig A (2000). Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice. Neuromusc Dis 10, 276 282.
20. Renganathan M, Messi ML, Schwartz R & Delbono O (1997). Overexpression of hIGF-1 exclusively in skeletal muscle increases the number of dihydropyridine receptors in adult transgenic mice. FEBS Lett 417, 13 16.
21. Schertzer JD, Gehrig SM, Ryall JG & Lynch GS (2007). Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am J Pathol 171, 1180 1188.
22. Schertzer JD & Lynch GS (2006). Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther 13, 1657 1664.
23. 2+-ATPase activity in aged rat skeletal muscle. Am J Physiol Endocrinol Metab 288, E526 E533.
24. Schertzer JD, Ryall JG & Lynch GS (2006). Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Am J Physiol Endocrinol Metab 291, E499 E505.
25. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT & Kelly AM (1991). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536 539.
26. 3IGF-I, ameliorates the loss of body weight but not of skeletal muscle during food restriction. Growth Horm IGF Res 11, 92 103.
27. Tomas FM, Lemmey AB, Read LC & Ballard FJ (1996). Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection. J Endocrinol 150, 77 84.
28. Webster C, Silberstein L, Hays AP & Blau HM (1988). Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52, 503 513.
29. Wiegand G & Remington SJ (1986). Citrate synthase: structure, control, and mechanism. Annu Rev Biophys Biophys Chem 15, 97 117.
30. 3IGF-I) and IGF-I via capture and identification of disulfide intermediates by cyanylation methodology and mass spectrometry. J Biol Chem 274, 37598 37604.
31. Zacharias JM & Anderson JE (1991). Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice. J Neurol Sci 104, 190 196.